【结 构 式】 |
【药物名称】Resiquimod, VML-600, R-848, S-28463 【化学名称】1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol 【CA登记号】144875-48-9 【 分 子 式 】C17H22N4O2 【 分 子 量 】314.39049 |
【开发单位】3M Pharmaceuticals (Originator), Lilly (Licensee) 【药理作用】Anti-Hepatitis C Virus Drugs, Anti-Hepatitis Virus Drugs, Anti-Herpes Virus Drugs, ANTIINFECTIVE THERAPY, Antiviral Drugs, IMMUNOMODULATING AGENTS, Immunomodulators, Interferon Inducers |
合成路线1
The esterification of 3-nitroquinoline-2,4-diol (I) with trifluoromethanesulfonic anhydride (II) gives the disulfonate (III), which is condensed with 2-hydroxyisobutylamine (IV) and triethylamine in dichloromethane, yielding the aminoquinoline (V). The reaction of (V) with dibenzylamine by means of triethylamine in refluxing toluene affords the quinolinediamine (VI), which by reduction of its nitro group with NaBH4 provides the quinolinetriamine (VII). The cyclization of (VII) with 2-ethoxyacetyl chloride (VIII) by means of p-toluenesulfonic acid in refluxing acetonitrile gives the protected imidazoquinoline (IX), which is finally deprotected by treatment with Pd/C and formic acid.
【1】 Graul, A.; Castañer, J.; S-28463. Drugs Fut 1999, 24, 6, 622. |
【2】 Gerster, J.F.; Crooks, S.L.; Lindstrom, K.J. (3M Pharmaceuticals); 1-Substd., 2-substd. 1H-imidazo[4,5-c]quinolin-4-amines. EP 0582581; JP 1994504789; US 5389640; WO 9215582 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 25005 | 3-nitro-2,4-quinolinediol | C9H6N2O4 | 详情 | 详情 | |
(II) | 25006 | 3,3-dioxo-1,3-bis(trifluoromethyl)-1lambda(6),3lambda(6)-dithioxane-1,1-dione | 358-23-6 | C2F6O5S2 | 详情 | 详情 |
(III) | 25007 | 3-nitro-4-[[(trifluoromethyl)sulfonyl]oxy]-2-quinolinyl trifluoromethanesulfonate | C11H4F6N2O8S2 | 详情 | 详情 | |
(IV) | 25008 | 1-amino-2-methylpropan-2-ol;1-amino-2-methyl-2-propanol;1,1-Dimethylethanolamine;2-Amino-a,a-dimethylethanol;2-Hydroxy-2-methyl-1-propylamine;2-Hydroxyisobutylamine;2-Methyl-2-hydroxypropylamine;3-Amino-2-methyl-2-propanol | 2854-16-2 | C4H11NO | 详情 | 详情 |
(V) | 25009 | 4-[(2-hydroxy-2-methylpropyl)amino]-3-nitro-2-quinolinyl trifluoromethanesulfonate | C14H14F3N3O6S | 详情 | 详情 | |
(VI) | 25010 | 1-[[2-(dibenzylamino)-3-nitro-4-quinolinyl]amino]-2-methyl-2-propanol | C27H28N4O3 | 详情 | 详情 | |
(VII) | 25011 | 1-[[3-amino-2-(dibenzylamino)-4-quinolinyl]amino]-2-methyl-2-propanol | C27H30N4O | 详情 | 详情 | |
(VIII) | 25012 | 2-ethoxyacetyl chloride | C4H7ClO2 | 详情 | 详情 | |
(IX) | 25013 | 1-[4-(dibenzylamino)-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methyl-2-propanol | C31H34N4O2 | 详情 | 详情 |
合成路线2
The cyclization of the diaminoquinoline (I) with ethoxyacetic acid (II) by heating at 120 C gives the imidazoquinoline (III), which is oxidized to the 5-N-oxide (IV) by treatment with peracetic acid. Finally, compound (IV) is aminated by means of ammonium hydroxide and p-toluenesulfonyl chloride in dichloromethane.
【1】 Graul, A.; Castañer, J.; S-28463. Drugs Fut 1999, 24, 6, 622. |
【2】 Nikolaides, N.; Lindstrom, K.J. (3M Pharmaceuticals); Process for preparing quinolone amines. WO 9417043 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 24965 | 1-[(3-amino-4-quinolinyl)amino]-2-methyl-2-propanol | C13H17N3O | 详情 | 详情 | |
(II) | 24966 | 2-ethoxyacetic acid | 627-03-2 | C4H8O3 | 详情 | 详情 |
(III) | 24967 | 1-[2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methyl-2-propanol | C17H21N3O2 | 详情 | 详情 | |
(IV) | 24968 | 2-(ethoxymethyl)-1-(2-hydroxy-2-methylpropyl)-1H-imidazo[4,5-c]quinolin-5-ium-5-olate | C17H21N3O3 | 详情 | 详情 |